The Effect of Metabolic Syndrome Status on Lung Function and Patient-reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

Background: Concurrent chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) represent an important clinical phenotype with overlapping symptomology. The effect of MetS in COPD patients was assessed following treatment with nebulized glycopyrrolate (GLY; administered via eFlow®...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Chronic Obstr Pulm Dis
Главные авторы: Carlin, Brian, Ferguson, Gary T., Ozol-Godfrey, Ayca, Goodin, Thomas, Sanjar, Shahin
Формат: Artigo
Язык:Inglês
Опубликовано: COPD Foundation Inc 2020
Предметы:
Origianl Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7883902/
https://ncbi.nlm.nih.gov/pubmed/32822528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.7.4.2020.0145
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы